StockData
Lexeo Therapeutics, Inc. logo

Lexeo Therapeutics, Inc. (LXEO) stock

LXEONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$2.85−0.38 (-11.61%)

Close on Nov 17, 2026Market cap $234.24MP/E –Yield –

Lexeo Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Lexeo Therapeutics's total assets was $254.90M at Jun 30, 2026. For fiscal 2025 it was $268.69M, up 82.9% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$268.69M+82.9%
FY2024Dec 31, 2024$146.94M+5.1%
FY2023Dec 31, 2023$139.81M+44.0%
FY2022Dec 31, 2022$97.08M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$254.90M+44.8%
Q1 FY2026Mar 31, 2026$250.36M+99.2%
Q4 FY2025Dec 31, 2025$268.69M+82.9%
Q3 FY2025Sep 30, 2025$143.84M-17.3%
Q2 FY2025Jun 30, 2025$176.07M-8.3%
Q1 FY2025Mar 31, 2025$125.69M-41.0%
Q4 FY2024Dec 31, 2024$146.94M+5.1%
Q3 FY2024Sep 30, 2024$173.87M+217.7%
Q2 FY2024Jun 30, 2024$192.01M+97.8%
Q1 FY2024Mar 31, 2024$213.21M–
Q4 FY2023Dec 31, 2023$139.81M–
Q3 FY2023Sep 30, 2023$54.72M–
Q4 FY2022Dec 31, 2022$97.08M–

More Lexeo Therapeutics figures

See a number that looks wrong?